Diagnostic Substances Industry

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of PEG ratio. Trinity Biotech plc (ADR) (NASDAQ: TRIB) has a PEG ratio of 0.55. Trinity Biotech's trailing-twelve-month revenue is $103.10 million. Meridian Bioscience, Inc. (NASDAQ: VIVO) has a PEG ratio of 1.24...

Below are the top diagnostic substances stocks on the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at SurModics, Inc. (NASDAQ: SRDX) is 33.60 percent. SurModics' PEG ratio is 2.06. The trailing-twelve-month operating margin at Meridian Bioscience, Inc. (NASDAQ...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings per share. The trailing-twelve-month earnings per share at Trinity Biotech plc (ADR) (NASDAQ: TRIB) is $1.22. Trinity Biotech's revenue for the same period is $105.10 million. The trailing-...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings per share. The trailing-twelve-month earnings per share at SurModics (NASDAQ: SRDX) is $0.96. SurModics' PEG ratio is 1.37. The trailing-twelve-month earnings per share at Meridian Bioscience (...

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on investment. The trailing-twelve-month return on investment at Nymox Pharmaceutical (NASDAQ: NYMX) is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.30 million. The trailing-twelve-month return on...

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Nymox Pharmaceutical (NASDAQ: NYMX) is 90.50%. Nymox Pharmaceutical's revenue for the same period is $3.20 million. The trailing-twelve-month return on equity...

Below are the top diagnostic substances stocks on the NASDAQ in terms of earnings per share. The trailing-twelve-month earnings per share at IDEXX Laboratories (NASDAQ: IDXX) is $3.52. IDEXX Laboratories' operating margin for the same period is 19.40%. The trailing-twelve-month earnings per share...

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Meridian Bioscience (NASDAQ: VIVO) is 21.50%. Meridian Bioscience's revenue for the same period is $188.10 million. The trailing-twelve-month return on assets...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. Trinity Biotech plc (NASDAQ: TRIB) is likely to earn $1.16 per share in the next year ending December, 2015. Trinity Biotech's trailing-twelve-month operating margin...

Below are the top diagnostic substances stocks on the NASDAQ in terms of PEG ratio. AMAG Pharmaceuticals (NASDAQ: AMAG) has a PEG ratio of 0.65. AMAG Pharma's trailing-twelve-month revenue is $80.86 million. Trinity Biotech plc (NASDAQ: TRIB) has a PEG ratio of 1.94. Trinity Biotech's trailing-...

Below are the small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Neogen (NASDAQ: NEOG) is $225.21 million. Neogen's ROE for the same period is 10.59%. The trailing-twelve-month revenue at Abaxis (NASDAQ: ABAX) is $188.77...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings per share. The trailing-twelve-month earnings per share at SurModics (NASDAQ: SRDX) is $0.99. SurModics' operating margin for the same period is 34.40%. The trailing-twelve-month earnings per...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Meridian Bioscience (NASDAQ: VIVO) is 21.19%. Meridian Bioscience had $44.28 million in total cash for the latest quarter. The trailing-...

Below are the small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Neogen (NASDAQ: NEOG) is $216.35 million. Neogen's ROE for the same period is 11.22%. The trailing-twelve-month revenue at Abaxis (NASDAQ: ABAX) is $188.77...

Below are the diagnostic substances stocks on the NASDAQ in terms of revenue. The trailing-twelve-month revenue at IDEXX Laboratories (NASDAQ: IDXX) is $1.34 billion. IDEXX's PEG ratio is 2.10. The trailing-twelve-month revenue at Neogen (NASDAQ: NEOG) is $216.35 million. Neogen's ROE for the...